BRYAN CAUDLE: Open Payments
NPI 1992196349 · PARADISE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 64 payments from 16 companies in 2025. Trend: 2023 $179 · 2024 $621 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $302 |
| Novo Nordisk Inc | 12 | $262 |
| PFIZER INC. | 4 | $97 |
| Exact Sciences Corporation | 4 | $75 |
| Dexcom, Inc. | 2 | $63 |
| Viatris Specialty LLC | 3 | $55 |
| KYOWA KIRIN, INC. | 2 | $54 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Abbott Laboratories | 2 | $47 |
Products named: Wegovy, QULIPTA, NURTEC ODT, UBRELVY, MAVYRET, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, YUPELRI.
Industry payments across CA — which companies pay providers there.
